[Executive Summary] Clinical Supplies - Made to Order

With the advent of personalized medication, ongoing developments in genetic and immunotherapies and the need to adapt to the requirements of patient-centric clinical trials, clinical supply chains are evolving. Clinical supply strategies need to balance the demand for speed, flexibility, cost and quality, whilst responding to the ever-changing regulatory environment.

Read the exec summary to get insights from industry experts on two dynamic, disruptive and different approaches to the standard ‘one size fits all’ traditional method for clinical trial supplies:
  • Demand-Led supply
  • Direct-to-Patient distribution

Sponsored by: